These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26252011)

  • 1. Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.
    Shen JH; Huang KY; Chao-Yu C; Chen CJ; Lin TY; Huang YC
    PLoS One; 2015; 10(8):e0134178. PubMed ID: 26252011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
    Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
    Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study.
    Bünzli D; Wietlisbach V; Barazzoni F; Sahli R; Meylan PR
    BMC Infect Dis; 2004 Mar; 4():10. PubMed ID: 15113449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland.
    Smith JS; Rosinska M; Trzcinska A; Pimenta JM; Litwinska B; Siennicka J
    Sex Transm Infect; 2006 Apr; 82(2):159-63. PubMed ID: 16581747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.
    Woestenberg PJ; Tjhie JH; de Melker HE; van der Klis FR; van Bergen JE; van der Sande MA; van Benthem BH
    BMC Infect Dis; 2016 Aug; 16():364. PubMed ID: 27484304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting.
    Russell DB; Tabrizi SN; Russell JM; Garland SM
    J Clin Virol; 2001 Oct; 22(3):305-13. PubMed ID: 11564596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus infection in the Croatian population.
    Vilibic-Cavlek T; Kolaric B; Ljubin-Sternak S; Mlinaric-Galinovic G
    Scand J Infect Dis; 2011 Dec; 43(11-12):918-22. PubMed ID: 21696254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany.
    Rabenau HF; Buxbaum S; Preiser W; Weber B; Doerr HW
    Med Microbiol Immunol; 2002 Mar; 190(4):153-60. PubMed ID: 12005327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
    Bradley H; Markowitz LE; Gibson T; McQuillan GM
    J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls.
    Stanberry LR; Rosenthal SL; Mills L; Succop PA; Biro FM; Morrow RA; Bernstein DI
    Clin Infect Dis; 2004 Nov; 39(10):1433-8. PubMed ID: 15546077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes.
    Wutzler P; Doerr HW; Färber I; Eichhorn U; Helbig B; Sauerbrei A; Brandstädt A; Rabenau HF
    J Med Virol; 2000 Jun; 61(2):201-7. PubMed ID: 10797375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel.
    Davidovici BB; Green M; Marouni MJ; Bassal R; Pimenta JM; Cohen D
    J Infect; 2006 May; 52(5):367-73. PubMed ID: 16213591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia.
    Uusküla A; Nygard-Kibur M; Cowan FM; Mayaud P; French RS; Robinson JN; Brown DW
    Scand J Infect Dis; 2004; 36(10):727-32. PubMed ID: 15513398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
    Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R
    Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HSV-1 and HSV-2 in Barbados.
    Levett PN
    Med Microbiol Immunol; 2005 Jan; 194(1-2):105-7. PubMed ID: 15156399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.
    Cunningham AL; Taylor R; Taylor J; Marks C; Shaw J; Mindel A
    Sex Transm Infect; 2006 Apr; 82(2):164-8. PubMed ID: 16581748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.
    Balaeva T; Grjibovski AM; Sidorenkov O; Samodova O; Firsova N; Sannikov A; Klouman E
    BMC Infect Dis; 2016 Oct; 16(1):616. PubMed ID: 27793121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus seroprevalence among children, adolescents and adults in Greece.
    Papadogeorgakis H; Caroni C; Katsambas A; Pimenta JM; Avdeliodi C; Kotrotsou T; Frangoulis E; Smith JS
    Int J STD AIDS; 2008 Apr; 19(4):272-8. PubMed ID: 18482949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.
    Xu F; Sternberg MR; Kottiri BJ; McQuillan GM; Lee FK; Nahmias AJ; Berman SM; Markowitz LE
    JAMA; 2006 Aug; 296(8):964-73. PubMed ID: 16926356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-specific herpes simplex virus-1 and herpes simplex virus-2 seroprevalence in Romania: comparison of prevalence and risk factors in women and men.
    Arama V; Cercel AS; Vladareanu R; Mihai C; Mihailescu R; Rankin J; Goschin S; Filipescu A; Rafila A; Arama S; Hristea A; Malkin JE; Pimenta JM; Smith JS
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e25-31. PubMed ID: 20106695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.